EDAP TMS S.A. (EDAP)
USD 2.16
(-12.2%)
USD 2.16
(-12.2%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 60.42 Million EUR | 7.4% |
| 2022 | 55.1 Million EUR | 25.06% |
| 2021 | 44.06 Million EUR | 5.77% |
| 2020 | 41.66 Million EUR | -7.23% |
| 2019 | 44.91 Million EUR | 14.62% |
| 2018 | 39.18 Million EUR | 9.61% |
| 2017 | 35.74 Million EUR | 0.38% |
| 2016 | 35.61 Million EUR | 10.41% |
| 2015 | 32.25 Million EUR | 20.41% |
| 2014 | 26.78 Million EUR | 11.24% |
| 2013 | 24.07 Million EUR | -7.62% |
| 2012 | 26.06 Million EUR | 16.93% |
| 2011 | 22.29 Million EUR | -5.97% |
| 2010 | 23.7 Million EUR | -4.73% |
| 2009 | 24.88 Million EUR | 7.95% |
| 2008 | 23.05 Million EUR | 3.09% |
| 2007 | 22.36 Million EUR | 10.35% |
| 2006 | 20.26 Million EUR | -2.55% |
| 2005 | 20.79 Million EUR | -6.11% |
| 2004 | 22.14 Million EUR | 20.1% |
| 2003 | 18.44 Million EUR | -7.7% |
| 2002 | 19.97 Million EUR | -16.78% |
| 2001 | 24 Million EUR | -12.15% |
| 2000 | 27.32 Million EUR | 42.6% |
| 1999 | 19.16 Million EUR | -17.37% |
| 1998 | 23.19 Million EUR | -29.13% |
| 1997 | 32.72 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 15.87 Million EUR | 5.3% |
| 2024 Q1 | 14.99 Million EUR | -21.53% |
| 2023 Q4 | 19.1 Million EUR | 62.82% |
| 2023 Q1 | 14.79 Million USD | -5.87% |
| 2023 Q3 | 11.73 Million EUR | -17.8% |
| 2023 FY | 59.18 Million EUR | 7.4% |
| 2023 Q2 | 14.27 Million EUR | -3.49% |
| 2022 Q1 | 12.99 Million EUR | -6.97% |
| 2022 FY | 55.1 Million EUR | 25.06% |
| 2022 Q4 | 15.71 Million EUR | 28.38% |
| 2022 Q3 | 12.24 Million EUR | -13.48% |
| 2022 Q2 | 14.15 Million EUR | 8.86% |
| 2021 FY | 44.06 Million EUR | 5.77% |
| 2021 Q4 | 13.97 Million EUR | 48.01% |
| 2021 Q3 | 9.44 Million EUR | -8.78% |
| 2021 Q2 | 10.34 Million EUR | 0.46% |
| 2021 Q1 | 10.3 Million EUR | -32.94% |
| 2020 Q3 | 9.43 Million EUR | 1.91% |
| 2020 Q1 | 7.61 Million EUR | -36.51% |
| 2020 Q2 | 9.25 Million EUR | 21.63% |
| 2020 FY | 41.66 Million EUR | -7.23% |
| 2020 Q4 | 15.36 Million EUR | 62.86% |
| 2019 Q1 | 10.13 Million EUR | -23.75% |
| 2019 Q2 | 12.48 Million EUR | 23.23% |
| 2019 Q4 | 11.98 Million EUR | -63.59% |
| 2019 FY | 44.91 Million EUR | 14.62% |
| 2019 Q3 | 32.92 Million EUR | 163.69% |
| 2018 Q4 | 13.28 Million EUR | 63.38% |
| 2018 FY | 39.18 Million EUR | 9.61% |
| 2018 Q3 | 8.13 Million EUR | -5.46% |
| 2018 Q2 | 8.6 Million EUR | -6.06% |
| 2018 Q1 | 9.15 Million EUR | -13.81% |
| 2017 Q2 | 9.32 Million EUR | 7.44% |
| 2017 Q4 | 10.62 Million EUR | 49.12% |
| 2017 FY | 35.74 Million EUR | 0.38% |
| 2017 Q1 | 8.67 Million EUR | -18.88% |
| 2017 Q3 | 7.12 Million EUR | -23.55% |
| 2016 Q4 | 10.69 Million EUR | 33.81% |
| 2016 FY | 35.61 Million EUR | 10.41% |
| 2016 Q2 | 8.19 Million EUR | -6.08% |
| 2016 Q1 | 8.72 Million EUR | -25.98% |
| 2016 Q3 | 7.99 Million EUR | -2.5% |
| 2015 Q2 | 7.83 Million EUR | 26.06% |
| 2015 Q3 | 6.4 Million EUR | -18.25% |
| 2015 Q4 | 11.79 Million EUR | 84.05% |
| 2015 FY | 32.25 Million EUR | 20.41% |
| 2015 Q1 | 6.21 Million EUR | -4.03% |
| 2014 Q2 | 5.63 Million EUR | -27.46% |
| 2014 Q3 | 6.91 Million EUR | 22.71% |
| 2014 Q4 | 6.47 Million EUR | -6.27% |
| 2014 Q1 | 7.76 Million EUR | -4.01% |
| 2014 FY | 26.78 Million EUR | 11.24% |
| 2013 Q3 | 5.56 Million EUR | 23.57% |
| 2013 FY | 24.07 Million EUR | -7.62% |
| 2013 Q1 | 5.92 Million EUR | -37.1% |
| 2013 Q4 | 8.08 Million EUR | 45.39% |
| 2013 Q2 | 4.5 Million EUR | -24.04% |
| 2012 Q4 | 9.42 Million EUR | 65.96% |
| 2012 FY | 26.06 Million EUR | 16.93% |
| 2012 Q3 | 5.67 Million EUR | -7.3% |
| 2012 Q1 | 4.83 Million EUR | -35.71% |
| 2012 Q2 | 6.12 Million EUR | 26.63% |
| 2011 Q4 | 7.52 Million EUR | 22.96% |
| 2011 Q2 | 3.79 Million EUR | -22.02% |
| 2011 Q1 | 4.86 Million EUR | -39.54% |
| 2011 FY | 22.29 Million EUR | -5.97% |
| 2011 Q3 | 6.11 Million EUR | 61.45% |
| 2010 FY | 23.7 Million EUR | -4.73% |
| 2010 Q4 | 8.03 Million EUR | 50.3% |
| 2010 Q1 | 4.33 Million EUR | -46.35% |
| 2010 Q2 | 5.98 Million EUR | 38.13% |
| 2010 Q3 | 5.34 Million EUR | -10.69% |
| 2009 Q3 | 4.62 Million EUR | -32.02% |
| 2009 Q1 | 5.36 Million EUR | -40.48% |
| 2009 FY | 24.88 Million EUR | 7.95% |
| 2009 Q4 | 8.08 Million EUR | 74.59% |
| 2009 Q2 | 6.8 Million EUR | 26.8% |
| 2008 Q1 | 4.34 Million EUR | -38.38% |
| 2008 FY | 23.05 Million EUR | 3.09% |
| 2008 Q4 | 9.02 Million EUR | 97.46% |
| 2008 Q3 | 4.56 Million EUR | -3.56% |
| 2008 Q2 | 4.73 Million EUR | 8.9% |
| 2007 Q1 | 4.6 Million EUR | -9.54% |
| 2007 Q2 | 5.95 Million EUR | 29.22% |
| 2007 Q3 | 4.68 Million EUR | -21.23% |
| 2007 FY | 22.36 Million EUR | 10.35% |
| 2007 Q4 | 7.05 Million EUR | 50.59% |
| 2006 Q1 | 5.17 Million EUR | -7.41% |
| 2006 Q4 | 5.09 Million EUR | 1.1% |
| 2006 Q3 | 5.03 Million EUR | -1.41% |
| 2006 Q2 | 5.1 Million EUR | -1.39% |
| 2006 FY | 20.26 Million EUR | -2.55% |
| 2005 Q2 | 5.11 Million EUR | -1.1% |
| 2005 Q1 | 5.17 Million EUR | -12.2% |
| 2005 FY | 20.79 Million EUR | -6.11% |
| 2005 Q4 | 5.59 Million EUR | 22.16% |
| 2005 Q3 | 4.57 Million EUR | -10.48% |
| 2004 Q1 | 5.65 Million EUR | 10.15% |
| 2004 Q4 | 5.89 Million EUR | 8.7% |
| 2004 Q2 | 5.18 Million EUR | -8.26% |
| 2004 FY | 22.14 Million EUR | 20.1% |
| 2004 Q3 | 5.41 Million EUR | 4.43% |
| 2003 Q3 | 4.56 Million EUR | -2.7% |
| 2003 Q1 | 4.38 Million EUR | -35.9% |
| 2003 Q2 | 4.69 Million EUR | 7.11% |
| 2003 Q4 | 5.13 Million EUR | 12.36% |
| 2003 FY | 18.44 Million EUR | -7.7% |
| 2002 Q4 | 6.84 Million EUR | 66.1% |
| 2002 FY | 19.97 Million EUR | -16.78% |
| 2002 Q3 | 4.11 Million EUR | -8.18% |
| 2002 Q2 | 4.48 Million EUR | -11.09% |
| 2002 Q1 | 5.04 Million EUR | -29.12% |
| 2001 Q3 | 5.21 Million EUR | -18.2% |
| 2001 Q2 | 6.38 Million EUR | 7.76% |
| 2001 Q1 | 5.92 Million EUR | -14.45% |
| 2001 FY | 24 Million EUR | -12.15% |
| 2001 Q4 | 7.11 Million EUR | 36.36% |
| 2000 Q3 | 7.93 Million EUR | 33.65% |
| 2000 Q1 | 5.55 Million EUR | 29.39% |
| 2000 Q2 | 5.93 Million EUR | 6.91% |
| 2000 FY | 27.32 Million EUR | 42.6% |
| 2000 Q4 | 6.92 Million EUR | -12.78% |
| 1999 Q2 | 4.82 Million EUR | -18.77% |
| 1999 FY | 19.16 Million EUR | -17.37% |
| 1999 Q1 | 5.94 Million EUR | -15.91% |
| 1999 Q4 | 4.29 Million EUR | 1.98% |
| 1999 Q3 | 4.2 Million EUR | -12.85% |
| 1998 Q3 | 3.73 Million EUR | -48.11% |
| 1998 Q1 | 6.12 Million EUR | -39.8% |
| 1998 FY | 23.19 Million EUR | -29.13% |
| 1998 Q4 | 7.07 Million EUR | 89.37% |
| 1998 Q2 | 7.19 Million EUR | 17.41% |
| 1997 Q3 | 8.2 Million EUR | 81.28% |
| 1997 Q4 | 10.18 Million EUR | 24.04% |
| 1997 FY | 32.72 Million EUR | 0.0% |
| 1997 Q1 | 4.56 Million EUR | 0.0% |
| 1997 Q2 | 4.52 Million EUR | -0.91% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alphatec Holdings, Inc. | 482.26 Million USD | 87.471% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -78326.613% |
| NeuroPace, Inc. | 65.42 Million USD | 7.64% |
| LENSAR, Inc. | 42.16 Million USD | -43.305% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -168.32% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -226.417% |
| Apyx Medical Corporation | 52.34 Million USD | -15.423% |
| Cutera, Inc. | 212.36 Million USD | 71.548% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -81.135% |
| BioSig Technologies, Inc. | 18 Thousand USD | -335583.333% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -401.061% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 96.08% |
| Axonics, Inc. | 366.37 Million USD | 83.508% |
| IRIDEX Corporation | 51.86 Million USD | -16.492% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 55.634% |
| TELA Bio, Inc. | 58.45 Million USD | -3.37% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -5038.01% |
| RxSight, Inc. | 89.07 Million USD | 32.168% |
| Align Technology, Inc. | 3.86 Billion USD | 98.436% |
| INVO Bioscience, Inc. | 3.02 Million USD | -1900.381% |
| electroCore, Inc. | 16.03 Million USD | -276.937% |
| Telesis Bio, Inc. | 27.5 Million USD | -119.648% |
| Viemed Healthcare, Inc. | 183 Million USD | 66.983% |
| Quipt Home Medical Corp. | 221.74 Million USD | 72.751% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 63.745% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -2388.591% |
| Dynatronics Corporation | 32.53 Million USD | -85.723% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -596.278% |
| Talis Biomedical Corporation | 412 Thousand USD | -14565.777% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -6137.496% |
| InMode Ltd. | 492.04 Million USD | 87.72% |
| Envoy Medical, Inc. | 316 Thousand USD | -19021.203% |
| Bruker Corporation | 2.96 Billion USD | 97.962% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -9282.453% |
| DexCom, Inc. | 3.62 Billion USD | 98.332% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -54458.999% |
| PAVmed Inc | 2.45 Million USD | -2364.233% |
| Viveve Medical, Inc. | 6.42 Million USD | -840.289% |
| Cerus Corporation | 156.36 Million USD | 61.358% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 68.695% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -54458.999% |
| IceCure Medical Ltd | 3.22 Million USD | -1771.26% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 91.919% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| 908 Devices Inc. | 50.22 Million USD | -20.295% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -152.235% |
| Orthofix Medical Inc. | 746.64 Million USD | 91.907% |
| Surmodics, Inc. | 126.07 Million USD | 52.075% |
| Nuwellis, Inc. | 8.86 Million USD | -581.667% |
| Outset Medical, Inc. | 130.37 Million USD | 53.655% |
| Venus Concept Inc. | 76.35 Million USD | 20.865% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 87.736% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 67.709% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -510.025% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| Inogen, Inc. | 315.66 Million USD | 80.858% |
| IRadimed Corporation | 65.56 Million USD | 7.839% |
| MaxCyte, Inc. | 41.28 Million USD | -46.345% |
| Pulmonx Corporation | 68.67 Million USD | 12.016% |
| PAVmed Inc. | 2.45 Million USD | -2364.233% |
| iCAD, Inc. | 17.31 Million USD | -248.903% |
| OrthoPediatrics Corp. | 148.73 Million USD | 59.375% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -16454.292% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -2994.741% |
| SI-BONE, Inc. | 138.88 Million USD | 56.495% |
| Semler Scientific, Inc. | 68.18 Million USD | 11.382% |
| Beyond Air, Inc. | 1.15 Million USD | -5113.374% |
| FONAR Corporation | 102.88 Million USD | 41.271% |
| AxoGen, Inc. | 159.01 Million USD | 62.001% |
| Biotricity, Inc. | 12.06 Million USD | -400.881% |
| Cytosorbents Corporation | 36.34 Million USD | -66.228% |
| ZimVie Inc. | 457.43 Million USD | 86.791% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 77.982% |
| Inari Medical, Inc. | 493.63 Million USD | 87.76% |
| UFP Technologies, Inc. | 400.07 Million USD | 84.897% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Sight Sciences, Inc. | 81.05 Million USD | 25.455% |
| Insulet Corporation | 1.69 Billion USD | 96.44% |
| Profound Medical Corp. | 7.33 Million USD | -724.21% |
| Bioventus Inc. | 512.34 Million USD | 88.207% |
| InspireMD, Inc. | 6.2 Million USD | -873.779% |
| BrainsWay Ltd. | 31.78 Million USD | -90.099% |
| BIOLASE, Inc. | 49.16 Million USD | -22.901% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -324754.839% |
| Tenon Medical, Inc. | 2.92 Million USD | -1963.627% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| CVRx, Inc. | 39.29 Million USD | -53.768% |
| AdaptHealth Corp. | 3.2 Billion USD | 98.112% |
| Sintx Technologies, Inc. | 2.62 Million USD | -2200.076% |
| Acutus Medical, Inc. | 7.16 Million USD | -743.425% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -337.816% |
| NanoVibronix, Inc. | 2.28 Million USD | -2546.649% |
| Quanterix Corporation | 122.36 Million USD | 50.622% |
| LivaNova PLC | 1.15 Billion USD | 94.762% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -787.003% |
| Varex Imaging Corporation | 811 Million USD | 92.55% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -147.585% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 69.867% |
| TransMedics Group, Inc. | 241.62 Million USD | 74.993% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -336.141% |
| NeuroMetrix, Inc. | 5.9 Million USD | -923.871% |
| Spectral AI, Inc. | 18.05 Million USD | -234.642% |
| Hyperfine, Inc. | 11.03 Million USD | -447.707% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 63.413% |
| Biomerica, Inc. | 5.41 Million USD | -1015.845% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -19.505% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 65.889% |